Acta Physiologica · 2008 · 36 citations · 36 references
MedicineGeneticsPhysiologyCardiovascular GeneticsElectrophysiologyMedical GeneticsAtrial ElectrophysiologyCardiac Ion ChannelsChannelopathiesInherited Arrhythmia SyndromesIon Channel DisordersSodium Channel BiophysicsCardiac Ion ChannelopathiesCardiac Sodium Channel DysfunctionChannelopathy MutationsHek293 Cell ExpressionIntraventricular Conduction DelayIon Channel Gene MutationsIon Channel MutationsMutation
AIM: We compared the clinical and physiological consequences of the novel mutation R878C in a highly conserved pore residue in domain II (S5-S6) of human, hNa(v)1.5, cardiac Na(+) channels. METHODS: Full clinical evaluation of pedigree members through three generations of a Chinese family combined with SCN5A sequencing from genomic DNA was compared with patch and voltage-clamp results from two independent expression systems. RESULTS: The four mutation carriers showed bradycardia, and slowed sino-atrial, atrioventricular and intraventricular conduction. Two also showed sick sinus syndrome; two had ST elevation in leads V1 and V2. Unlike WT-hNa(v)1.5, whole-cell patch-clamped HEK293 cells expressing R878C-hNa(v)1.5 showed no detectable Na(+) currents (i(Na)), even with substitution of a similarly charged lysine residue. Voltage-clamped Xenopus oocytes injected with either 0.04 or 1.5 microg microL(-1) R878C-hNa(v)1.5 cRNA similarly showed no i(Na), yet WT-hNa(v)1.5 cRNA diluted to 0.0004-0.0008 ng microL(-1)resulted in expression of detectable i(Na). i(Na) was simply determined by the amount of injected WT-hNa(v)1.5: doubling the dose of WT-hNa(v)1.5 cRNA doubled i(Na). i(Na) amplitudes and activation and inactivation characteristics were similar irrespective of whether WT-hNa(v)1.5 cRNA was given alone or combined with equal doses of R878C-hNa(v)1.5 cRNA therefore excluding dominant negative phenotypic effects. Na(+) channel function in HEK293 cells transfected with R878C-hNa(v)1.5 was not restored by exposure to mexiletine (200 microM) and lidocaine (100 microM). Fluorescence confocal microscopy using E3-Nav1.5 antibody demonstrated persistent membrane expression of both WT and R878C-hNa(v)1.5. Modelling studies confirmed that such i(Na) reductions reproduced the SSS phenotype. CONCLUSION: Clinical consequences of the novel R878C mutation correlate with results of physiological studies.
36
Genetic basis and molecular mechanism for idiopathic ventricular fibrillation
Qiuyun Chen, Glenn E. Kirsch, Danmei Zhang et al. · Nature · 1998 · 1.8K citations
Medicine, Cardiology, Genetics +16
SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome
Qing Wang, Jiaxiang Shen, Igor Splawski et al. · Cell · 1995 · 1.7K citations · Full text
Natural History of Brugada Syndrome
Silvia G. Priori, Carlo Napolitano, Maurizio Gasparini et al. · Circulation · 2002 · 1K citations
Medicine, Cardiology, Genetics +17
Molecular mechanism for an inherited cardiac arrhythmia
Paul B. Bennett, Kazuto Yazawa, Naomasa Makita et al. · Nature · 1995 · 967 citations